INTRODUCTION
Africa constitutes 20.4% of the land mass on earth and is home to 11.9% of its people (1) (http://www.who.int/evidence/bod). It is a continent of contrasts in terms of its people, cultures and disease patterns, harbouring a great burden of infectious disease yet characterized by a steady increase in noncommunicable chronic conditions. There are areas where famine is endemic and people survive on meagre diets, contrasted by the rise in obesity in areas where calorie-rich diets are abundant and affordable, even to the poor. An epidemiological transition is in various states of progression throughout the continent resulting in a reduction in communicable disease in some regions with a concurrent rise in chronic diseases of lifestyle (2) . The interplay between genetic variation and the spectrum of environmental exposures shapes disease profiles. A genomic and molecular understanding of these processes provides unique opportunities for public health intervention on the continent. In addition, it provides an opportunity to explore unprecedented genetic diversity for clues to physiological adaptation mechanisms in a resource poor environment and new drug targets for common diseases.
The African continent houses 52 independent countries cutting across linguistic, biological, cultural and geographic barriers. Table 1 provides a snapshot of the economic standing, life expectancy at birth, infant and childhood mortality and deaths from non-communicable diseases across the continent, ranked according to population size. It is clear that these countries perform poorly compared with the developed world where, for example, the USA has an infant mortality of 7 per 1000 live births, male life expectancy of 76 years and female life expectancy of 81 years. There is a stark contrast in the prevalence of infectious diseases and noncommunicable diseases when comparing statistics from Africa to that of Europe, and even to the average for the world (Fig. 1) .
There is a legacy of historical migration, admixture and assimilation across the African continent. A genetic study on 121 African populations revealed 14 ancestral biological population clusters (3) , and studies on hunter-gather * To whom correspondence should be addressed at: Division of Human Genetics, National Health Laboratory Service, PO populations of east and southern Africa affirm that they harbor the highest levels of genetic diversity and despite their small numbers remain surprisingly differentiated (4, 5) . Considering this high level of genetic diversity and advances in more affordable and high-throughput 'omics' biology, what are some of the genomic research priorities that would lead to an improvement in public health status among Africans, and what role could this play in the discovery of genetic determinants that contribute to the global understanding of disease?
GENOMIC KNOWLEDGE TRANSLATION AND AFRICAN GENOMIC DATA
Integrating knowledge about gene function, genome structure, chromatin organization, recombination rates, mutation processes and evolutionary history is fundamental to understanding the human genome and how it relates to health and disease. There is marked genetic substructure in human populations, with Africans as no exception (3,6 -8) . Differences between populations are characterized by different mutations and frequencies of disease-related variants. Most of the genetic variation observed in human populations occurs among Africans, with only a subset of this diversity found in non-African populations (9 -12). Until relatively recently, the origin and dispersal of human populations focused on the two haploid genetic markers, namely mitochondrial DNA and the nonrecombining region of Y chromosome (10) (11) (12) (13) (14) . Recent advances, however, following the completion of the human reference genome sequence in 2003 (15) and the genomes of many individuals, including the first two southern African genomes (16) , have improved the resolution of genomic data in assessing population structure and in studies examining gene function, genetic susceptibility to disease and human evolution. Genetic variation forms the scaffold onto which studies on disease susceptibility are assembled. A review published by Sirugo et al. in 2008 summarized genetic and genomic studies in African populations (17) . Since then, significantly more African genome data have become available in the public domain from multiple sources and many are available through genome browsers such as Ensembl, UCSC and the NCBI. The two most abundant sources of the data are the HapMap Project (18) and the 1000 Genomes Project (19) , but smaller studies contribute to data which can be accessed through SNP database and individual publications. HapMap data are available for the following African populations: Yoruba from Ibadan in Nigeria, Luhya from Webuye in Kenya and the Maasai from Kinyawa, also in Kenya (20) . The objective of the 1000 Genomes Project is the deep characterization of human genome sequence variation as a foundation for investigating the relationship between genotype and phenotype (19) and data from additional African populations from Malawi, The Gambia and Ghana, and three populations with African admixture (resident in the USA and Caribbean), will soon become available in the public domain ( Fig. 2A) .
The HapMap project, in particular, has contributed significantly in elucidating the structure of human genetic variation and the fundamental molecular and evolutionary processes that shape it (18). Genome-wide association studies (GWASs) have become a popular method for identifying genomic loci that contribute to complex traits (21) . These studies have to date focused largely on European populations, with only a few studies including African populations. As of June 2011, the GWAS catalogue includes 932 publications and 4617 significantly associated SNPs, with 54 studies including at least one population with an African-derived gene pool (22, 23) . Most of these, however, are admixed African populations mainly of West African origin, many of whom reside in developed countries. The studies include GWAS for complex traits including neuropsychiatric, cardiovascular and kidney disease, as well as prostate cancer and asthma (Fig. 2B) . Studies on admixed African populations will provide valuable insight into disease aetiology on the continent (24) . A striking example of a strong genotype -phenotype correlation among Africans is the discovery that HIV-associated nephropathy is associated with common genetic variation at the MYH9/APOL1 locus. Specific alleles 
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are highly correlated with an increased risk for developing end-stage renal disease (25) . There are six GWASs on non-admixed African study cohorts. Five have examined host susceptibility to HIV, tuberculosis (TB) and malaria (26) (27) (28) (29) (30) , and one focused on genomic association for anthropometric traits (31) . A novel genetic variant was identified, using GWAS, for susceptibility to TB. The variant, identified from studying over 11 000 individuals from Ghana, The Gambia and Malawi, was localized to a gene-sparse region of chromosome 18, suggesting a possible role in gene regulation (30) . The MalariaGEN consortium (http://www.malariagen.net) examined genome-wide genetic association with severe malaria in The Gambia and demonstrated that weak linkage disequilibrium can affect signal strength in an African population. Fine mapping and multipoint imputation based on population-specific sequencing will enhance the capacity for identifying causal variants in African populations (28, 32) .
HOST-PATHOGEN INTERACTIONS IN SHAPING THE GENOME
Host genetic variability translates to various phenotypic outcomes which encompass (i) susceptibility to microbe infection, (ii) disease severity in the case of acute infections, (iii) variable rates of disease progression in the case of chronic infectious diseases (e.g. HIV), (iv) differential immune response to vaccination, and (v) differential host response to treatments (pharmacogenetics; measures of drug efficacy or toxicity). Many pathogens have evolved elaborate means of evading host immune responses to ensure their perpetuation (33) (34) (35) (36) (37) , and phenotypic outcome of pathogen-host interaction is influenced by pathogen variability and virulence. Host genetics affect commensal organism or the microbiota composition, in turn the microbiota play a critical role in maturation of the immune system (38) . Perturbations of the symbiotic relationship between the human host and the microbiota predispose the host to infection.
Superimposed on the scenario of host-pathogen-microbiome interaction is the influence of environment which includes geographical location, climate (e.g. affects distribution of vectors for vector-borne diseases), diet (influences composition of the microbiome), the extent of pathogen exposure (pathogen load, case contact), co-infections, interventions for prevention and treatment and emergence of drug-resistant variants of pathogens.
In Africa, the interface between genomics and infectious diseases is particularly important because of the high disease burden, and complex infectious diseases with high prevalence rates such as HIV, TB and malaria remain a major challenge.
The importance of population-based genetic differences and their influence on phenotypic outcomes is highlighted by examples in the field of HIV-1. Two of the most polymorphic regions of the human genome, the killer immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) gene loci, code for cell surface molecules of critical importance in innate and adaptive immune defence against infectious organisms, the most studied being HIV-1 (39). The extensive variation at both these loci (40, 41) demonstrates the selective pressures imposed on host populations by microbes over evolutionary time. GWASs conducted on non-African HIV-1-infected individuals have identified the HLA locus as a major region involved in control of HIV-1 infection (42) . Frequencies of HLA alleles and KIR genes can vary dramatically between different populations. For example, particular HLA alleles shown to be associated with slower HIV-1 disease in Caucasians may be infrequent or absent in certain African populations and vice versa (43) . Also, while KIR2DS1 and KIR3DS1 are common in Caucasian populations, these genes are rarely found on KIR haplotypes in African populations (44) . The number of GWAS studies that include at least one population with African ancestry and the traits which were investigated.
* SLE, systemic lupus erythematosus.
CCR5 is a chemokine receptor which serves as one of the major HIV coreceptors for virus entry (45, 46) . The most studied CCR5 variant associated with protection from HIV-1 infection (47), the CCR5△32 allele, occurs in 4 -15% in Caucasian populations but is virtually absent in Asian and African populations (48) . CCR5 haplotypes associated with accelerated or delayed HIV-1 disease progression are different among African Americans and Caucasians (49) . These same genetic differences have been confirmed, and extended haplotypes described, among South African, African and Caucasian individuals (50) .
It is clear that a better understanding of the complexities of inter-related components of host -pathogen -microbiome environment will allow improved interventions for prevention and treatments that will consider specific population groups, and ultimately the individual, as personalized medicine becomes a closer reality.
RELATIVE CONTRIBUTIONS OF ENVIRONMENTAL SELECTION AND GENETIC DRIFT
After dispersal from Africa, substantial phenotypic variation characterized by variation in skin, hair and eye colour, body mass, height, diet, drug metabolism, susceptibility and resistance to disease have been observed in non-Africans (51) . It has been suggested that populations colonizing novel habitats have been confronted by new selective pressures due to their exposure to different climates, food sources and pathogens (52) . Moreover, most of the genes thought to be under the influence of strong selection show marked differences in frequencies (typically larger than 20%) between African and non-African populations.
African populations have also experienced drastic changes in their environment during the past 50 000 years (53) . Some examples of genetic adaptation in Africa include b-globin (54), G6PD (55) and lactose tolerance (56). Hofer et al. (52) argue that demographic factors (like genetic drift and gene flow), rather than selection alone, provide a more complete explanation of the genetic differentiation in Africa. Whereas many models propose that natural selection acts only on a single gene or a group of functionally related genes, demographic history tends to influence all loci in the genome equally (51) . Recent whole-genome data suggest that classic selective sweeps, as a result of natural selection, have not been a common phenomenon in our recent history (57) . It is more likely that selection acts on many loci simultaneously to effect genetic adaptation through a process of modulating allele frequencies of existing genetic variants (58) . More refined statistical methods are needed to investigate these possibilities and fortunately a rapidly increasing number of studies are focused on teasing out the effects of different evolutionary forces and the extent to which they play a role in shaping genomes with respect to disease traits. This will be an important challenge if we are to understand the complexity of disease in Africa.
CHALLENGES
Realizing the potential of the genomic revolution for the benefit of Africans on the continent is premised on the ability to overcome significant challenges. It is made all the more difficult because of the enormous disparities between countries and, with a few exceptions, the lack of adequate healthcare infrastructure. Some priorities to meet these challenges are outlined in Table 2 and emphasize the need for skilled capacity development among scientists in African countries. However, working on the African continent also presents many interesting opportunities (Table 2 ) and in response, several large-scale studies have been initiated, including the Human Heredity and Health in Africa Initiative and the Southern African Human Genome Programme that is currently under development.
An international survey of genomics in developing countries identified five-key factors for the development of successful national genomics initiatives: political will, institutional leadership, local health needs, a respect for genomic sovereignty and a knowledge-based economy (59) . Coupled with these is a need for sustainable funding, collaboration, regulatory infrastructure, healthcare infrastructure and public awareness and education.
CONCLUSIONS
Africans harbour a spectrum of genetic variation ranging from the most ancient variations present at the beginnings of our species to the more recently assimilated variants from nonAfrican sources, including varying degrees of admixture across time. African populations have a pivotal role to play 
Priorities
† Develop policies to protect genomic sovereignty for the benefit of the people of Africa † Develop and support national and regional human genome programmes † Develop expertise in genomic and epigenetic data analysis so that studies can be analysed in situ † Develop strategies and opportunities for African scientists to return to work in their countries of origin † Develop and implement educational strategies to inform the medical fraternity and public about genomics and ethical issues in genome research and personalized medicine † Provide broadband computer access across the continent Opportunities † Understand genomic signatures of selection and adaptation in Africans and how they reflect past environmental exposures and inform current susceptibility to disease † Study genetic variation that affects pharmacogenomically relevant loci and use this information to provide guidelines for drug use in African populations † Examine genomic and epigenetic variation in the context of common, complex disease and mortality in urban and rural settings † Identify the biological 'drivers' of infectious disease epidemics (environment, pathogen and host) and the development of immune responses in Africans † Study the microbiome in Africans to understand adaptation to diet and environmental influences on host-microbiome interactions, in order to inform strategies to improve public health R218 Human Molecular Genetics, 2011, Vol. 20, Review Issue 2 in unravelling the complexities created between the genome and environment that have shaped human populations, which will undoubtedly lead to new discoveries of genetic contributors to health and disease. Future initiatives will benefit from a better understanding of nature's adaptive strategies on the continent.
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